Cost of antibiotics and painkillers have registered a marginal hike in cost starting April 1 with the drug price regulator National Pharmaceutical Pricing Authority’s (NPPA) latest notification allowing price hike for select medicines by 0.00551%.
While the marginal hike has come as a relief for consumers pharmaceutical companies claim that they are grappling with rising cost of raw material and tightening price control mechanisms. The Department of Pharmaceuticals has now issued its annual list of revised ceiling prices for 923 scheduled drug formulations and revised retail prices of 65 formulations with the ceiling rates coming into effect from April 1. This revision is part of routine exercise undertaken by the NPPA.
Also read | Pharmaceuticals Department forms panel to reform prices of drugs and medical devices
